FDA Seeking Public Comments Regarding Prospective CBD Marketing Rules | NORML
SILVER SPRING, MD — The US Food and Drug Administration has scheduled a public hearing to address issues surrounding the “safety, manufacturing, product quality, marketing, labeling, and sale” of products containing hemp-derived cannabinoids such as CBD. Outgoing FDA Commissioner Scott Gottlieb announced that the public meeting will take place on May 31st at the agency’s White Oak […]
FDA Seeking Public Comments Regarding Prospective CBD Marketing Rules | The Daily Chronic
http://www.thedailychronic.net/2019/94383/fda-seeking-public-comments-regarding-prospective-cbd-marketing-rules/
